TIENGO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 8.620
AS - Asia 2.240
EU - Europa 1.378
SA - Sud America 383
AF - Africa 350
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 21
Totale 13.030
Nazione #
US - Stati Uniti d'America 8.412
SG - Singapore 702
CN - Cina 599
HK - Hong Kong 371
BR - Brasile 263
FI - Finlandia 207
SE - Svezia 192
VN - Vietnam 192
DE - Germania 179
FR - Francia 109
UA - Ucraina 106
GB - Regno Unito 91
PL - Polonia 66
RU - Federazione Russa 64
IT - Italia 58
IN - India 34
IE - Irlanda 27
TR - Turchia 26
NL - Olanda 25
AR - Argentina 18
MX - Messico 18
MY - Malesia 17
TH - Thailandia 16
BB - Barbados 15
ES - Italia 15
IS - Islanda 15
ZA - Sudafrica 15
GT - Guatemala 14
IQ - Iraq 14
PE - Perù 14
PH - Filippine 14
SK - Slovacchia (Repubblica Slovacca) 14
TT - Trinidad e Tobago 14
CA - Canada 13
HT - Haiti 13
JO - Giordania 13
NO - Norvegia 13
NZ - Nuova Zelanda 13
VE - Venezuela 13
AT - Austria 12
DJ - Gibuti 12
EG - Egitto 12
GH - Ghana 12
KE - Kenya 12
MD - Moldavia 12
PY - Paraguay 12
RS - Serbia 12
SN - Senegal 12
TN - Tunisia 12
UY - Uruguay 12
YT - Mayotte 12
BO - Bolivia 11
CO - Colombia 11
CW - ???statistics.table.value.countryCode.CW??? 11
CY - Cipro 11
DO - Repubblica Dominicana 11
DZ - Algeria 11
EC - Ecuador 11
ID - Indonesia 11
KY - Cayman, isole 11
LA - Repubblica Popolare Democratica del Laos 11
MA - Marocco 11
MN - Mongolia 11
PS - Palestinian Territory 11
RO - Romania 11
UZ - Uzbekistan 11
AM - Armenia 10
BE - Belgio 10
BF - Burkina Faso 10
BY - Bielorussia 10
CG - Congo 10
CU - Cuba 10
CZ - Repubblica Ceca 10
EE - Estonia 10
GA - Gabon 10
HR - Croazia 10
IL - Israele 10
JP - Giappone 10
KG - Kirghizistan 10
ME - Montenegro 10
NE - Niger 10
NG - Nigeria 10
NI - Nicaragua 10
PK - Pakistan 10
AZ - Azerbaigian 9
BD - Bangladesh 9
CL - Cile 9
GE - Georgia 9
GF - Guiana Francese 9
HN - Honduras 9
KH - Cambogia 9
LB - Libano 9
MG - Madagascar 9
NP - Nepal 9
PR - Porto Rico 9
SD - Sudan 9
TJ - Tagikistan 9
TZ - Tanzania 9
UG - Uganda 9
ZM - Zambia 9
Totale 12.647
Città #
Fairfield 1.323
Woodbridge 783
Chandler 670
Houston 634
Jacksonville 584
Ashburn 563
Ann Arbor 483
Wilmington 482
Seattle 474
Cambridge 459
Singapore 399
Hong Kong 362
Princeton 201
Boardman 181
Beijing 167
Dong Ket 155
Roxbury 123
San Diego 123
Santa Clara 120
Nanjing 93
Helsinki 70
Guangzhou 68
Des Moines 64
Medford 62
Bytom 53
Shenyang 34
Hebei 30
Shanghai 27
Nanchang 26
Norwalk 26
Council Bluffs 24
Dublin 23
Los Angeles 23
Munich 23
New York 21
Jiaxing 20
Changsha 15
George Town 14
São Paulo 14
Reykjavik 13
San Francisco 13
Accra 12
Amman 12
Dakar 12
Guatemala City 12
Ho Chi Minh City 12
London 12
Montevideo 12
Hanoi 11
Hefei 11
Nuremberg 11
Tashkent 11
Tianjin 11
Turku 11
Bridgetown 10
Libreville 10
Managua 10
Redwood City 10
Ulan Bator 10
Baku 9
Bishkek 9
Boston 9
Brooklyn 9
Dallas 9
Djibouti 9
Dushanbe 9
Kampala 9
Podgorica 9
Auckland 8
Bangkok 8
Cayenne 8
Chicago 8
Kigali 8
Kuala Lumpur 8
Lima 8
Mamoudzou 8
Nairobi 8
Noumea 8
Padova 8
Port-au-Prince 8
Tallinn 8
Vientiane 8
Yerevan 8
Zurich 8
Abidjan 7
Andorra la Vella 7
Belo Horizonte 7
Castries 7
Dar es Salaam 7
Dearborn 7
Harare 7
Havana 7
Lusaka 7
Nassau 7
Niamey 7
Ogden 7
Panama City 7
Phnom Penh 7
Ramallah 7
Rio de Janeiro 7
Totale 9.563
Nome #
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 170
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 169
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 169
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 169
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 154
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 153
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 152
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 152
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 151
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 148
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 144
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 143
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 143
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 142
Endothelial progenitor cells and the diabetic paradox. 142
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 141
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 137
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 136
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 136
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 134
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 134
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 133
Mechanisms of acute and chronic hypoglycemic action of gliclazide 133
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 130
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 129
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 129
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 127
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 127
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 124
The metabolic syndrome, diabetes and lung dysfunction. 122
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 120
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 119
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 118
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia 118
Non esterified fatty acids and endothelial dysfunction 116
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 116
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 114
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 113
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 113
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 113
Dose-response curves of effects of insulin on leucine kinetics in humans. 113
The use of degrees of certainty to evaluate knowledge 112
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 112
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 111
The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. 111
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 111
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 110
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 110
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 109
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 109
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 108
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 108
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 107
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 107
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 106
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 106
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus 104
Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects. 103
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 103
Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus 103
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 103
Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. 103
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 103
The effects of oral amino acid intake on ambulatory capacity in elderly subjects 102
The metabolic syndrome, diabetes and lungdysfunction. 102
Continuous subcutaneous insulin infusion (CSII) in Italy 102
Glucose tolerance is negatively associated with circulating progenitor cell levels. 102
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 102
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 102
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 101
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 100
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 98
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 98
Characteristics and mortality oftype 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia. 97
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. 97
First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen. 95
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 94
Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state. 93
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 93
Alcohol impairs insulin sensitivity in normal subjects. 92
Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: The Cornell voltage 91
Ketone body metabolism in normal and diabetic human skeletal muscle. 91
Role of intra-arterial calcium injection test and venous sampling (IACI) as localizing procedure in insulinomas. 90
Model of the kinetics of ketone bodies in humans. 90
PROTEIN METABOLISM IN GLUCAGONOMA. 89
INTRA-ARTERIAL CALCIUM INJECTION TEST AS LOCALIZING PROCEDURE IN INSULINOMAS. 89
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations 89
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 87
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. 87
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 87
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 87
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 86
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 86
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 85
Visceral obesity is characterized by impaired nitric oxide-independent vasodilation 85
Continuous glucose monitoring in conditions other than diabetes 85
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 82
A post-hypoglycaemic increase of lactate can rescue cognitive function and counterregulatory responses to hypoglycaemia 82
Oral amino acids in elderly subjects: Effect on myocardial function and walking capacity 80
Extreme but asymptomatic hypergastrinemia with gastroparesis in a young woman with insulin dependent diabetes mellitus. 79
Totale 11.302
Categoria #
all - tutte 43.735
article - articoli 38.674
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 773
Totale 83.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.356 0 0 23 135 87 164 39 142 230 118 186 232
2021/20221.633 23 191 219 109 64 120 74 162 98 25 200 348
2022/20231.319 248 142 9 179 206 174 1 110 171 7 57 15
2023/2024503 18 87 56 38 30 32 16 9 16 80 52 69
2024/20252.183 6 182 136 84 297 37 85 144 195 74 409 534
2025/20261.648 236 822 590 0 0 0 0 0 0 0 0 0
Totale 13.035